Cargando…

Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients

BACKGROUND: Acute myeloid leukemia (AML) is a group of highly heterogenous and aggressive blood cancer. Despite recent progress in its diagnosis and treatment, patient outcome is variable and drug resistance results in increased mortality. The siglec family plays an important role in tumorigenesis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Huiping, Gao, Liang, Zhang, Weili, Jiang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295398/ https://www.ncbi.nlm.nih.gov/pubmed/35854240 http://dx.doi.org/10.1186/s12859-022-04841-5

Ejemplares similares

Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature
por: Fu, Denggang, et al.
Publicado: (2021)

Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia
por: Zhong, Fangmin, et al.
Publicado: (2023)

Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia
por: Chen, Miao, et al.
Publicado: (2022)

Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes
por: Ke, Peng, et al.
Publicado: (2023)

Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy
por: Chang, Huijuan, et al.
Publicado: (2018)

Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia
por: Shi, Mingguang, et al.
Publicado: (2019)

A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018)

Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
por: Ren, Xiyang, et al.
Publicado: (2022)

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients
por: Zhu, Ruiqi, et al.
Publicado: (2020)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
por: Wang, Huiping, et al.
Publicado: (2020)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

A three-gene signature might predict prognosis in patients with acute myeloid leukemia
por: Zhu, Xin, et al.
Publicado: (2020)

A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia
por: Huang, Kecheng, et al.
Publicado: (2022)

Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients
por: Chaudhary, Shilpi, et al.
Publicado: (2023)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
por: Li, Baihui, et al.
Publicado: (2020)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Comparison of (68)Ga-DOTA-Siglec-9 and (18)F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry
por: Virtanen, Helena, et al.
Publicado: (2017)

A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia
por: Lai, Yanli, et al.
Publicado: (2021)

HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia
por: Zhang, Xiaoning, et al.
Publicado: (2022)

m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia
por: Fu, Caizhu, et al.
Publicado: (2023)

Integration of CD34(+)CD117(dim) population signature improves the prognosis prediction of acute myeloid leukemia
por: Li, Xue-Ping, et al.
Publicado: (2022)

A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia
por: Zhu, Ruiqi, et al.
Publicado: (2017)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia
por: Gao, Yan, et al.
Publicado: (2022)

Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia
por: Chen, Si-Liang, et al.
Publicado: (2020)

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
por: Li, Guilan, et al.
Publicado: (2020)

Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
por: Blöchl, Constantin, et al.
Publicado: (2023)

CDK9 inhibitors in acute myeloid leukemia
por: Boffo, Silvia, et al.
Publicado: (2018)

A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia
por: Jiang, Feng, et al.
Publicado: (2021)

A 29‐gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival
por: Ijurko, Carla, et al.
Publicado: (2022)

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment
por: Fu, Denggang, et al.
Publicado: (2023)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia
por: Pillsbury, Claire E., et al.
Publicado: (2023)

Expression and prognosis of the B7 family in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)

Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8uluudbd3hfqstsnb8f3j48sof